TrialNature medicine2024

Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial.

Danijela Tatovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.